Clara Klerk

1.6k total citations
18 papers, 1.1k citations indexed

About

Clara Klerk is a scholar working on Internal Medicine, Hematology and Oncology. According to data from OpenAlex, Clara Klerk has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Internal Medicine, 7 papers in Hematology and 4 papers in Oncology. Recurrent topics in Clara Klerk's work include Venous Thromboembolism Diagnosis and Management (12 papers), Acute Myeloid Leukemia Research (3 papers) and Central Venous Catheters and Hemodialysis (3 papers). Clara Klerk is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (12 papers), Acute Myeloid Leukemia Research (3 papers) and Central Venous Catheters and Hemodialysis (3 papers). Clara Klerk collaborates with scholars based in Netherlands, Italy and Belgium. Clara Klerk's co-authors include Harry R. Büller, Dick J. Richel, Susanne M. Smorenburg, Tatjana M.H. Niers, Martin H. Prins, Anthonie W.A. Lensing, Geertjan van Tienhoven, Hans-Martin Otten, Paolo Prandoni and Monique M.E.M. Bos and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Clara Klerk

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clara Klerk Netherlands	9	535	279	245	234	218	18	1.1k
A.K. Kakkar United Kingdom	13	508 0.9×	376 1.3×	269 1.1×	95 0.4×	286 1.3×	28	1.0k
Mark G. Wahrenbrock United States	6	253 0.5×	188 0.7×	219 0.9×	35 0.1×	140 0.6×	7	753
M F Scully United Kingdom	20	364 0.7×	534 1.9×	272 1.1×	28 0.1×	251 1.2×	41	1.4k
Francesca Elice Italy	17	203 0.4×	654 2.3×	455 1.9×	47 0.2×	134 0.6×	32	1.2k
Ilene C. Weitz United States	21	165 0.3×	800 2.9×	136 0.6×	63 0.3×	102 0.5×	84	1.9k
Carlo L. Balduini Italy	20	60 0.1×	674 2.4×	181 0.7×	29 0.1×	99 0.5×	52	1.1k
Leonard T. Heffner United States	21	68 0.1×	1.1k 3.8×	687 2.8×	75 0.3×	22 0.1×	68	1.7k
C N Chesterman Australia	15	83 0.2×	336 1.2×	114 0.5×	14 0.1×	130 0.6×	32	775
Tracy Proverbs‐Singh United States	7	126 0.2×	34 0.1×	210 0.9×	21 0.1×	93 0.4×	14	1.1k
J M Freyssinet France	13	142 0.3×	460 1.6×	670 2.7×	5 0.0×	134 0.6×	18	1.3k

Countries citing papers authored by Clara Klerk

Since Specialization

Citations

This map shows the geographic impact of Clara Klerk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Klerk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Klerk more than expected).

Fields of papers citing papers by Clara Klerk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Klerk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Klerk. The network helps show where Clara Klerk may publish in the future.

Co-authorship network of co-authors of Clara Klerk

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Klerk. A scholar is included among the top collaborators of Clara Klerk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Klerk. Clara Klerk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wang, Steven, Marcel Nijland, Rinske Boersma, et al.. (2025). Prospective validation of end of treatment ctDNA-MRD by PhasED-Seq in DLBCL patients from a national trial.. Journal of Clinical Oncology. 43(16_suppl). 7000–7000.

Duetz, Carolien, Marcel Nijland, Marjolein van der Poel, et al.. (2024). Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS. Blood Advances. 8(5). 1094–1104. 2 indexed citations

Breems, Dimitri, Clara Klerk, Thomas Pabst, et al.. (2023). A Novel Prognostic Model for Patients with Acute Myeloid Leukemia in First Relapse with Improved Prognostic Accuracy. Blood. 142(Supplement 1). 724–724. 1 indexed citations

Werkhoven, Erik van, Marcel Nijland, Koen de Heer, et al.. (2021). High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Treated with DA-EPOCH-R Induction and Nivolumab Consolidation Treatment: Interim Results of the HOVON-152 Phase II Trial. Blood. 138(Supplement 1). 1414–1414. 1 indexed citations

Klerk, Clara, et al.. (2017). Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience. PLoS ONE. 12(10). e0187184–e0187184. 19 indexed citations

Libourel, Eduard J., Clara Klerk, Yvette van Norden, et al.. (2016). OC-10 - Disseminated intravascular coagulation at diagnosis strongly predicts both arterial and venous thrombosis in acute myeloid leukemia patients. Thrombosis Research. 140. S172–S172. 1 indexed citations

Libourel, Eduard J., Clara Klerk, Yvette van Norden, et al.. (2016). Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood. 128(14). 1854–1861. 84 indexed citations

Klerk, Clara, Tatjana M.H. Niers, Lois W. Brüggemann, et al.. (2009). Prophylactic plasma levels of the low molecular weight heparin nadroparin does not affect colon cancer tumor development in mouse liver. Thrombosis Research. 125(3). 235–238. 4 indexed citations

Niers, Tatjana M.H., Lois W. Brüggemann, Clara Klerk, et al.. (2008). Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clinical & Experimental Metastasis. 26(3). 171–178. 26 indexed citations

10.

Niers, Tatjana M.H., Marcello Di Nisio, Clara Klerk, et al.. (2007). Prevention of catheter‐related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo‐controlled study. Journal of Thrombosis and Haemostasis. 5(9). 1878–1882. 69 indexed citations

11.

Klerk, Clara, Susanne M. Smorenburg, C. Arnold Spek, & Cornelis J.F. Van Noorden. (2007). Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation. Journal of Cellular and Molecular Medicine. 11(3). 561–568. 11 indexed citations

12.

Klerk, Clara, Renée M. Overmeer, Tatjana M.H. Niers, et al.. (2007). Validity of Bioluminescence Measurements for Noninvasive in Vivo Imaging of Tumor Load in Small Animals. BioTechniques. 43(sup1). 7–13, 30. 119 indexed citations

13.

Niers, Tatjana M.H., Clara Klerk, C. J. F. van Noorden, et al.. (2006). Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Critical Reviews in Oncology/Hematology. 61(3). 195–207. 172 indexed citations

14.

Klerk, Clara, Susanne M. Smorenburg, Hans-Martin Otten, et al.. (2005). The Effect of Low Molecular Weight Heparin on Survival in Patients With Advanced Malignancy. Journal of Clinical Oncology. 23(10). 2130–2135. 481 indexed citations

15.

Nisio, Marcello Di, et al.. (2004). Antithrombotic therapy and cancer. Current Opinion in Hematology. 11(3). 187–191. 3 indexed citations

16.

Klerk, Clara & Harry R. Büller. (2004). Thrombosis Prophylaxis in Cancer Patients With a Central Venous Catheter—Reply. Archives of Internal Medicine. 164(4). 459–459. 5 indexed citations

17.

Klerk, Clara, Susanne M. Smorenburg, Hans‐Martin Otten, et al.. (2004). Low-molecular-weight heparin and the survival of patients with advanced malignancy. Journal of Clinical Oncology. 22(14_suppl). 8018–8018. 2 indexed citations

18.

Klerk, Clara, Susanne M. Smorenburg, & Harry R. Büller. (2003). Thrombosis Prophylaxis in Patient Populations With a Central Venous Catheter. Archives of Internal Medicine. 163(16). 1913–1913. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact